Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes

Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes

Abstract Aims The aim of this study was to evaluate the safety profile in terms of changes in renal function after co‐treatment with sacubitril/valsartan and empagliflozin in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction (HFrEF). Methods and results This multic...

Full description

Bibliographic Details
Main Authors: Rafael de laEspriella, Antoni Bayés‐Genís, Herminio Morillas, Rafael Bravo, Verónica Vidal, Eduardo Núñez, Enrique Santas, Gema Miñana, Juan Sanchis, Lorenzo Fácila, Francisco Torres, Jose Luis Górriz, Alfonso Valle, Julio Núñez
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:ESC Heart Failure
Subjects:
Heart failure with reduced ejection fraction (HFrEF)
Type 2 diabetes mellitus
Sacubitril/valsartan
SGLT2i
Renal function
Renal safety profile
Online Access:https://doi.org/10.1002/ehf2.12965

Internet

https://doi.org/10.1002/ehf2.12965

Similar Items